Morpholino

MO5-actn2b

ID

ZDB-MRPHLNO-121120-4

Name

MO5-actn2b

Previous Names

E7 MO (1)

Target

actn2b (1)

Sequence

5' - TTTATGCTTATGGTTTACCCTCTGC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO5-actn2b

No data available

Phenotype

Phenotype resulting from MO5-actn2b

Phenotype	Fish	Figures
cardiac muscle cell decreased amount, abnormal	WT + MO5-actn2b	Fig. 6, Fig. 7 from Yang et al., 2012
cardiac muscle cell decreased size, abnormal	WT + MO5-actn2b	Fig. 6, Fig. 7 from Yang et al., 2012
cardiac muscle cell shape, abnormal	WT + MO5-actn2b	Fig. 6 from Yang et al., 2012
cardiac muscle cell Z disc broken, abnormal	WT + MO5-actn2b	Fig. 4 from Yang et al., 2012
cardiac muscle cell Z disc increased width, abnormal	WT + MO5-actn2b	Fig. 4, Fig. 8 from Yang et al., 2012
cardiac muscle cell Z disc shape, abnormal	WT + MO5-actn2b	Fig. 4 from Yang et al., 2012
pericardium edematous, abnormal	WT + MO5-actn2b	Fig. 2 from Yang et al., 2012
ventricular myocardium decreased size, abnormal	xu060Tg + MO5-actn2b	Fig. 6 from Yang et al., 2012
ventricular myocardium decreased volume, abnormal	xu060Tg + MO5-actn2b	Fig. 6, Fig. 7, Fig. 8 from Yang et al., 2012
ventricular myocardium cardiac chamber ballooning decreased occurrence, abnormal	xu060Tg + MO5-actn2b	Fig. 6 from Yang et al., 2012

Phenotype of all Fish created by or utilizing MO5-actn2b

Phenotype	Fish	Conditions	Figures
cardiac muscle cell Z disc increased width, abnormal	WT + MO5-actn2b	standard conditions	Fig. 4 from Yang et al., 2012
cardiac muscle cell shape, abnormal	WT + MO5-actn2b	standard conditions	Fig. 6 from Yang et al., 2012
cardiac muscle cell Z disc shape, abnormal	WT + MO5-actn2b	standard conditions	Fig. 4 from Yang et al., 2012
cardiac muscle cell decreased amount, abnormal	WT + MO5-actn2b	standard conditions	Fig. 6, Fig. 7 from Yang et al., 2012
cardiac muscle cell decreased size, abnormal	WT + MO5-actn2b	standard conditions	Fig. 6, Fig. 7 from Yang et al., 2012
cardiac muscle cell Z disc broken, abnormal	WT + MO5-actn2b	standard conditions	Fig. 4 from Yang et al., 2012
ventricular myocardium decreased volume, abnormal	WT + MO5-actn2b	standard conditions	Fig. 7 from Yang et al., 2012
pericardium edematous, abnormal	WT + MO5-actn2b	standard conditions	Fig. 2 from Yang et al., 2012
cardiac muscle cell sarcomere disorganized, abnormal	xu060Tg + MO5-actn2b	chemical treatment: blebbistatin	Fig. 8 from Yang et al., 2012
heart contraction arrested, abnormal	xu060Tg + MO5-actn2b	chemical treatment: nifedipine	Fig. 8 from Yang et al., 2012
ventricular myocardium decreased size, abnormal	xu060Tg + MO5-actn2b	standard conditions	Fig. 6 from Yang et al., 2012
cardiac muscle cell Z disc increased width, abnormal	xu060Tg + MO5-actn2b	chemical treatment: blebbistatin	Fig. 8 from Yang et al., 2012
heart contraction arrested, abnormal	xu060Tg + MO5-actn2b	chemical treatment: blebbistatin	Fig. 8 from Yang et al., 2012
ventricular myocardium decreased volume, abnormal	xu060Tg + MO5-actn2b	standard conditions	Fig. 6, Fig. 8 from Yang et al., 2012
cardiac muscle cell Z disc decreased length, abnormal	xu060Tg + MO5-actn2b	chemical treatment: blebbistatin	Fig. 8 from Yang et al., 2012
ventricular myocardium cardiac chamber ballooning decreased occurrence, abnormal	xu060Tg + MO5-actn2b	standard conditions	Fig. 6 from Yang et al., 2012
cardiac muscle cell Z disc increased width, abnormal	xu060Tg + MO5-actn2b	standard conditions	Fig. 8 from Yang et al., 2012
cardiac muscle cell sarcomere disorganized, abnormal	xu060Tg + MO5-actn2b	chemical treatment: nifedipine	Fig. 8 from Yang et al., 2012
cardiac muscle cell decreased amount, abnormal	WT + MO1-tnnt2a + MO5-actn2b	standard conditions	Fig. 7 from Yang et al., 2012
cardiac muscle cell sarcomere disorganized, abnormal	WT + MO1-tnnt2a + MO5-actn2b	standard conditions	Fig. 7 from Yang et al., 2012
cardiac muscle cell Z disc shape, abnormal	WT + MO1-tnnt2a + MO5-actn2b	standard conditions	Fig. 7 from Yang et al., 2012
heart contraction arrested, abnormal	WT + MO1-tnnt2a + MO5-actn2b	standard conditions	Fig. 7 from Yang et al., 2012
cardiac muscle cell Z disc increased width, abnormal	xu061Tg + MO5-actn2b	standard conditions	Fig. 3 from Yang et al., 2012
heart contraction process quality, abnormal	xu062Tg + MO5-actn2b	standard conditions	Fig. 5 from Yang et al., 2012

Citations